We've found
620
archived clinical trials in
ADHD
We've found
620
archived clinical trials in
ADHD
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Updated: 1/4/2016
A Multicenter, Dose-optimized, Double-blind, Randomized, Placebo-controlled Study To Evaluate The Efficacy Of Nwp09 In Pediatric Patients With Attention Deficit Hyperactivity Disorder (Adhd) In A Laboratory Classroom
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
Updated: 2/1/2016
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
Status: Enrolling
Updated: 2/1/2016
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
Updated: 2/1/2016
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
Status: Enrolling
Updated: 2/1/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
The Efficacy and Safety of PRC-063 in Adult ADHD Patients
Updated: 2/17/2016
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Multi-Center Study Measuring the Efficacy and Safety of PRC-063 in Adult ADHD Patients
Status: Enrolling
Updated: 2/17/2016
Click here to add this to my saved trials
Attention Intervention Management
Updated: 3/7/2016
Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Attention Intervention Management
Status: Enrolling
Updated: 3/7/2016
Attention Intervention Management
Updated: 3/7/2016
Rehabilitation Research and Training Center for Traumatic Brain Injury Interventions--Attention Intervention Management
Status: Enrolling
Updated: 3/7/2016
Click here to add this to my saved trials
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Updated: 3/14/2016
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/14/2016
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Updated: 3/14/2016
A Double-Blind Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
Updated: 3/18/2016
A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled, Crossover Study to Evaluate the Efficacy of AR11 (Amphetamine Sulfate) in Pediatric Patients (Ages 6-12) With Attention Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom
Status: Enrolling
Updated: 3/18/2016
Click here to add this to my saved trials